Jinhe Biotechnology Co Ltd (002688) — Strategic Asset Allocation Index
Jinhe Biotechnology Co Ltd (002688) has a Strategic Asset Allocation Index of 70.5% as of September 2023. Strategic assets (PP&E of CN¥1.79 Billion plus long-term investments of CN¥-) total CN¥1.79 Billion, measured against net assets of CN¥2.54 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Jinhe Biotechnology Co Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Jinhe Biotechnology Co Ltd Strategic Asset Allocation Index (2009–2022)
This chart shows how Jinhe Biotechnology Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of September 2023, the index stands at 70.5%, representing strategic assets of CN¥1.79 Billion against net assets of CN¥2.54 Billion CNY. See Jinhe Biotechnology Co Ltd (002688) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Jinhe Biotechnology Co Ltd (2009–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jinhe Biotechnology Co Ltd from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Jinhe Biotechnology Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 66.9% | CN¥1.62 Billion | CN¥1.62 Billion | CN¥- | CN¥2.43 Billion | ▲ +22.1 pp |
| 2021 | 44.8% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥2.70 Billion | ▼ -14.9 pp |
| 2020 | 59.7% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥1.75 Billion | ▲ +5.9 pp |
| 2019 | 53.9% | CN¥973.07 Million | CN¥973.07 Million | CN¥- | CN¥1.81 Billion | ▲ +4.6 pp |
| 2018 | 49.3% | CN¥876.78 Million | CN¥874.64 Million | CN¥2.14 Million | CN¥1.78 Billion | ▲ +2.4 pp |
| 2017 | 46.9% | CN¥768.29 Million | CN¥766.90 Million | CN¥1.38 Million | CN¥1.64 Billion | ▲ +3.8 pp |
| 2016 | 43.2% | CN¥683.57 Million | CN¥682.79 Million | CN¥776.03K | CN¥1.58 Billion | ▼ -31.8 pp |
| 2015 | 75.0% | CN¥790.68 Million | CN¥565.44 Million | CN¥225.23 Million | CN¥1.05 Billion | ▲ +23.8 pp |
| 2014 | 51.2% | CN¥489.17 Million | CN¥489.17 Million | CN¥- | CN¥956.13 Million | ▲ +2.5 pp |
| 2013 | 48.6% | CN¥437.71 Million | CN¥437.71 Million | CN¥- | CN¥900.07 Million | ▲ +10.4 pp |
| 2012 | 38.2% | CN¥330.00 Million | CN¥330.00 Million | CN¥- | CN¥863.55 Million | ▼ -64.1 pp |
| 2011 | 102.3% | CN¥342.03 Million | CN¥342.03 Million | CN¥- | CN¥334.40 Million | ▼ -23.1 pp |
| 2010 | 125.4% | CN¥319.60 Million | CN¥319.60 Million | CN¥- | CN¥254.83 Million | ▼ -28.0 pp |
| 2009 | 153.4% | CN¥300.65 Million | CN¥300.65 Million | CN¥- | CN¥196.03 Million | — |